Mitsubishi UFJ Asset Management
VERV

Mitsubishi UFJ Asset Management’s Verve Therapeutics VERV Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-54,824
Closed -$251K – 1645
2025
Q1 		$251K Buy
54,824
+4,594
+9% +$30.8K ﹤0.01% 934
2024
Q4 		$313K Buy
50,230
+2,742
+6% +$15.5K ﹤0.01% 926
2024
Q3 		$230K Sell
47,488
-4,483
-9% -$26K ﹤0.01% 946
2024
Q2 		$254K Buy
51,971
+32,958
+173% +$207K ﹤0.01% 933
2024
Q1 		$252K Sell
19,013
-871
-4% -$11.6K ﹤0.01% 934
2023
Q4 		$258K Buy
19,884
+3,405
+21% +$42.2K ﹤0.01% 985
2023
Q3 		$219K Buy
16,479
+871
+6% +$14K ﹤0.01% 1013
2023
Q2 		$293K Buy
+15,608
New +$260K ﹤0.01% 989

Other funds holding VERV

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return